Literature DB >> 15023329

[When the risk exceeds the benefit].

M Blasco Oliete.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15023329      PMCID： PMC7668676          DOI： 10.1016/s0212-6567(04)79400-7

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  3 in total

Review 1.  Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.

Authors:  J B Segal; R L McNamara; M R Miller; N R Powe; S N Goodman; K A Robinson; E B Bass
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 2.  Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.

Authors:  O Benavente; R Hart; P Koudstaal; A Laupacis; R McBride
Journal:  Cochrane Database Syst Rev       Date:  2000

3.  Epidemiologic features of chronic atrial fibrillation: the Framingham study.

Authors:  W B Kannel; R D Abbott; D D Savage; P M McNamara
Journal:  N Engl J Med       Date:  1982-04-29       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.